U.S. vaccine market to hit $17B by 2018; Military research probes HIV weaknesses to find vaccine;

> Scientists from the U.S. Military HIV Research Program in Maryland think they are finding weaknesses in HIV that can lead to an effective vaccine. Story

> A study by Transparency Market Research shows the U.S. vaccines market will reach $17.4 billion by 2018. More

> Austrian biotech Intercell launched its JEEV vaccine to combat Japanese encephalitis in India. News

> In New Zealand, doctors are recording a spike in demand for the meningococcal C vaccine, after a 12-year-old girl succumbed to it and died. Story

> Interim results from a Phase II trial conducted in India to test a tuberculosis vaccine are expected to be released "soon," according to The Hindu. Article

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.